APA (7th ed.) Citation

B, P., I, M., A, L., & KL, L. (2012). A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 31(10), 2703. https://doi.org/10.1007/s10096-012-1617-7

Chicago Style (17th ed.) Citation

B, Paes, Mitchell I, Li A, and Lanctôt KL. "A Comparative Study of Respiratory Syncytial Virus (RSV) Prophylaxis in Premature Infants Within the Canadian Registry of Palivizumab (CARESS)." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 31, no. 10 (2012): 2703. https://doi.org/10.1007/s10096-012-1617-7.

MLA (9th ed.) Citation

B, Paes, et al. "A Comparative Study of Respiratory Syncytial Virus (RSV) Prophylaxis in Premature Infants Within the Canadian Registry of Palivizumab (CARESS)." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 31, no. 10, 2012, p. 2703, https://doi.org/10.1007/s10096-012-1617-7.